- FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.on December 20, 2024 at 10:47 pm
The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.
- FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortageon December 19, 2024 at 6:01 pm
The decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.
- Why Americans are outraged over health insurance — and what could changeon December 19, 2024 at 12:56 pm
The shooting of Brian Thompson has unleashed a torrent pent-up of anger towards insurers, renewed calls for reform and reignited a debate over U.S. health care
- Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing dealon December 18, 2024 at 3:26 pm
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.
- Health AI startup Suki expands partnership with Google Cloud to deliver more assistive tech for clinicianson December 18, 2024 at 12:00 pm
Health-care AI startup Suki is building patient summary and Q&A features using Google Cloud's Vertex AI platform.
- Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye conditionon December 17, 2024 at 8:59 pm
A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 80% of doctors are using telemedicine weekly, a new Doximity report finds.
- Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levelson December 17, 2024 at 2:00 pm
Dexcom is bringing generative AI to Stelo users, starting with weekly personalized reports about their glucose